You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 21 No. 3, September 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (90)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Monoamine Oxidase Inhibition in the Treatment of Migraine

Michael Anthony, MD; James W. Lance, MD

Arch Neurol. 1969;21(3):263-268.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE WIDESPREAD use of monoamine oxidase (MAO) inhibitors followed the simultaneous discovery that iproniazid phosphate caused euphoria in tuberculous patients1 and inhibited monoamine oxidase.2 Since then, they have formed an important group of antidepressant drugs. The clinically important monoamine oxidases are present in the granular fraction of most parenchymatous tissues of vertebrates where they deaminate several aliphatic and aromatic amines, including serotonin (5-hydroxytryptamine [5HT] ), dopamine, tryptamine, tyramine, and, to a lesser extent, epinephrine and norepinephrine. Administration of MAO inhibitors increases the concentration of these amines in many organs, including blood platelets, which contain about 99% of blood 5HT.3

Spontaneous migraine is associated with a fall in plasma 5HT and increased urinary excretion of both 5-hydroxyindole acetic acid (5HIAA)4,5 and 5 HT (unpublished observations). Depletion of platelet 5HT by the intramuscular administration of reserpine induces migraine in susceptible individuals, and intravenous 5HT relieves-both spontaneous and reserpine-induced . . . [Full Text PDF of this Article]


Author Affiliations

Sidney, New South Wales, Australia

From the Division of Neurology, Prince Henry Hospital, and the School of Medicine, University of New South Wales, Sydney, Australia.


Footnotes

Submitted for publication Jan 29, 1969; accepted May 19.

Reprint requests to Division of Neurology, Prince Henry Hospital, Little Bay, New South Wales 2036, Australia (Dr. Anthony).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.